Andrew Rankin, PhD, Bcmas
About Andrew Rankin, PhD, Bcmas
Andrew Rankin, PhD, Bcmas, serves as the Associate Director of Medical Affairs at Day One Biopharmaceuticals, where he has worked since 2021. With a strong background in oncology and personalized medicine, he has held various positions at Foundation Medicine and has an extensive academic history from Boston University School of Medicine.
Work at Day One Biopharmaceuticals
Andrew Rankin serves as the Associate Director of Medical Affairs at Day One Biopharmaceuticals, a position he has held since 2021. In this role, he focuses on advancing the company's mission to improve cancer care through innovative therapies. His responsibilities include overseeing medical strategies and ensuring the integration of scientific data into clinical practices. His experience in medical affairs supports the company's commitment to personalized medicine.
Previous Experience in Medical Affairs
Prior to his current role, Andrew Rankin worked at Foundation Medicine in various capacities. He served as Senior Manager of Medical Affairs from 2018 to 2020 and then as Associate Director of Medical Affairs from 2020 to 2021. His tenure at Foundation Medicine also included roles as Lead Operations Manager and Operations Manager in Translational Oncology and Clinical Reporting, as well as Biomedical Informatics Scientist I. This extensive experience in medical affairs has equipped him with a deep understanding of oncology and personalized medicine.
Education and Expertise
Andrew Rankin earned his Ph.D. in Cell and Molecular Biology from Boston University School of Medicine, where he studied from 2004 to 2011. He also holds a Bachelor of Science degree in Biology with a minor in Chemistry from Eastern Nazarene College, completed between 2000 and 2004. His educational background provides a solid foundation for his work in oncology and personalized medicine, emphasizing the importance of molecular information in transforming cancer care.
Teaching Experience
In addition to his roles in the pharmaceutical industry, Andrew Rankin has experience in academia. He served as Head Instructor at Boston University Metropolitan College from 2008 to 2014. In this capacity, he contributed to the education of students in the field of biology, sharing his knowledge and expertise in scientific principles and practices.
Advocacy and Focus Areas
Andrew Rankin advocates for the expansion of personalized medicine, particularly in the context of childhood cancer. He emphasizes the importance of addressing significant challenges in oncology through unity and empowerment. His work reflects a commitment to improving patient outcomes by leveraging molecular information to guide treatment decisions.